Eli Marie Grindedal
0000-0002-8198-1706
Publication & Citation Trends
Publications
0 total
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
Cited by 0
Semantic Scholar
A clinical pilot study for personalized risk?based breast cancer screening utilizing the polygenic risk score
Cited by 0
Semantic Scholar
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study
Cited by 0
Semantic Scholar
Performance of a blood-biomarker test for early detection of pancreatic ductal adenocarcinoma (PDAC) across all stages of disease versus a mixed control population.
Cited by 0
Semantic Scholar
Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma.
Cited by 8
Semantic Scholar
S5 High Performance of a Blood-Based Biomarker Test to Detect Early-Stage Pancreatic Cancer in a High-Risk Population, Across 2 Independent Clinical Validation Studies
Cited by 0
Semantic Scholar
Abstract CT088: Clinical validation of a novel blood-based protein multi-analyte test for early detection of pancreatic ductal adenocarcinoma (PDAC) in a large, independent high-risk patient population
Cited by 0
Semantic Scholar
806: CLINICAL VALIDATION OF A NOVEL BLOOD-BASED MULTI-BIOMARKER TEST FOR THE EARLY DETECTION OF PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IN AN INDEPENDENT HIGH-RISK POPULATION SHOWS SIMILAR HIGH PERFORMANCE AS OBSERVED IN ITS MODEL DEVELOPMENT STUDY
Cited by 0
Semantic Scholar
Research Topics
Genetic factors in colorectal cancer
(18)
BRCA gene mutations in cancer
(17)
Genetic Associations and Epidemiology
(16)
Prostate Cancer Treatment and Research
(16)
Cancer Genomics and Diagnostics
(14)
Affiliations
University of Southern California
Oslo University Hospital
Royal Marsden NHS Foundation Trust
Institute of Cancer Research
University of Oslo